Key Highlights
- CareCloud, Inc. (NASDAQ:CCLD) rose 23.33% to USD 2.22 during trading on November 5, 2026, according to published market data, after the company described its third quarter as its most profitable ever.
- Third-quarter Revenue reached USD 33.7 million, a 9% increase from USD 31.1 million, while GAAP Net Income climbed 54% to USD 4.7 million.
- Adjusted EBITDA hit USD 9.9 million, up 28%, with a 29% margin, while GAAP EPS came in at USD 0.10 versus USD 0.04.
- Full-year 2026 targets were left unchanged: revenue of USD 128 million to USD 132 million and adjusted EBITDA of USD 29 million to USD 31 million.
Record Quarter Announced November 5, 2026
CareCloud released third-quarter 2026 results on November 5, 2026. Revenue came to USD 33.7 million, a 9% rise from USD 31.1 million. GAAP net income totaled USD 4.7 million compared with USD 3.1 million, and net income attributable to common holders was USD 4.2 million versus USD 1.7 million. GAAP Operating Income reached USD 6.6 million against USD 3.2 million, adjusted EBITDA stood at USD 9.9 million compared with USD 7.7 million, while GAAP EPS landed at USD 0.10 versus USD 0.04. Chief Executive Stephen Snyder labeled it the most lucrative three months in the company's history and linked that momentum to keeping full-year guidance unchanged.
Margins, Cash and How Debt Changed
Across the first nine months, revenue reached USD 96.9 million, a 13% gain from USD 86.1 million, while adjusted EBITDA came to USD 21.2 million versus USD 19.9 million. For the nine-month period, GAAP net income came to USD 6.8 million versus USD 7.9 million, and Operating Cash Flow totaled USD 16.3 million against USD 19.9 million. Chief Strategy Officer A. Hadi Chaudhry said staff handle more Volume without adding people, crediting automation and offshore delivery. The firm bought back its Series B Preferred Shares on May 15, 2026 by drawing on a Credit facility. That ended a preferred Dividend yet increased borrowing: term and other loans reached USD 37.3 million at September 30, 2026, up from USD 1.2 million at year-end 2025, while cash stood at USD 4.6 million.
Risks and Items to Monitor
The reaffirmed guidance implies a step up. Nine-month adjusted EBITDA of USD 21.2 million, measured against a full-year band of USD 29 million to USD 31 million, implies roughly USD 7.8 million to USD 9.8 million in the fourth quarter. Shareholders' Equity dropped to USD 22.6 million from USD 59.5 million following the buyback, interest expense is now a meaningful cost and cash is tight. Market Capitalization sits near USD 94.34 million, according to published market data. With daily volume near 933,000 shares and a micro-cap profile, a handful of trades can push the price around, bid-ask gaps may be wide and a quoted gain may fade. Investors will watch the fourth-quarter report and debt paydown.
Where Things Stand
The jump at CareCloud, Inc. (NASDAQ:CCLD) points to a distinct operating win: a peak in GAAP net income, a peak in adjusted EBITDA and an unchanged outlook following a quarter in which profit outpaced revenue. Whether that lasts is less clear. Revenue growth of 9% is moderate, the Balance Sheet now holds USD 37.3 million of loans and a price near USD 2.22 invites swings. The next test is whether fourth-quarter adjusted EBITDA hits the level the USD 29 million to USD 31 million guidance implies and if free cash flow can fund debt reduction.



![Psyched Wellness Secures Fresh Loan as Capital Structure Comes Into Focus [CN:PSYC]](/featured_image/gallery/medium/F9(4)_11_09_2026_14_30_36_330855.jpg)
![Telo Genomics Adds US$250K Loan as Diagnostic Development Advances [TSXV:TELO]](/featured_image/gallery/medium/shutterstock_2512738327_11_09_2026_14_30_41_206255.jpg)

Please wait processing your request...